Impact of PCI appropriateness in the long-term outcomes of consecutive patients treated with second-generation drug-eluting stents

Seixas, Ana Cristina; Sousa, Amanda; Costa Junior, Jose de Ribamar; Moreira, Adriana Costa; Costa, Ricardo; Damiani, Lucas; Campos Neto, Cantídio; Maldonado, Galo; Cano, Manuel; Sousa, J. Eduardo.
J Invasive Cardiol ; 29(9): 290-296, 2017.
Artigo Inglês | SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1063695

Documentos relacionados

  1. Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents.
  2. Long-term results of myocardial revascularization in patients with multivessel disease.
  3. Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation: The Importance of Stent Size.
  4. Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis.
  5. Angiographic late lumen loss revisited: impact on long-term target lesion revascularization.
  6. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
  7. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI.
  8. RAPSTROM™ first-in-man study long-term results of a biodegradable polymer sustained-release sirolimus-eluting stent in de novo coronary stenoses.
  9. [Recent progress in application of local drug delivery for preventing restenosis after peripheral arterial revascularization].
  10. Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents.